Fig. 2. Percent of subjects avoiding any allogeneic and preoperative autologous donation transfusions in the (A ) intent-to-treat population (n = 492), (B ) protocol-defined target population with blood loss 20 ml/kg or greater (n = 330), and (C ) clinical benefit group (post hoc  analysis), i.e. , patients with surgical blood loss 10 ml/kg or greater (n = 424). *P < 0.05 between groups.